Lanxess Sets Its Sights on Turkey's Growing Market

Specialty chemicals company Lanxess plans to expand further in the Turkish market. It takes one important step in this direction by officially opening its new subsidiary in Istanbul.

Lanxess Kimya Ticaret will manage the company's business in this growing market in the future.

Lanxess generated record sales in Turkey in 2011 amounting to some €125 million, nearly triple the amount achieved in 2009. The company anticipates that the Turkish economy will grow between 4 and 5% a year between 2013 and 2016, significantly faster than Western Europe.

Lanxess markets its entire range of products in Turkey, from high-performance polymers and specialty chemicals to quality chemical intermediates. Activities focus on high-performance rubber products, rubber chemicals and high-tech plastics for the automotive sector, as well as color pigments for the construction industry. Lanxess previously organized its operations in the country via external distributors.

The most important sectors in Turkey for Lanxess are the automotive and tire industries. The company expects the automotive industry in Turkey to grow by 8.5% in 2013 and then 3.5% per year from 2014 to 2016. In the construction industry, Lanxess foresees growth rates of between 4 and 5% in the upcoming years.

The new company will initially start off with 20 employees under the management of Ömer Bakir, general manager of Lanxess Kimya Ticaret Ltd. Åžti.

 

 

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.